• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多能干细胞中脊髓小脑共济失调 7 型的分子和电生理特征。

Molecular and electrophysiological features of spinocerebellar ataxia type seven in induced pluripotent stem cells.

机构信息

Department of Human Biology, University of Cape Town, South Africa.

Neuroscience Institute, University of Cape Town, South Africa.

出版信息

PLoS One. 2021 Feb 24;16(2):e0247434. doi: 10.1371/journal.pone.0247434. eCollection 2021.

DOI:10.1371/journal.pone.0247434
PMID:33626063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7904216/
Abstract

Spinocerebellar ataxia type 7 (SCA7) is an inherited neurodegenerative disease caused by a polyglutamine repeat expansion in the ATXN7 gene. Patients with this disease suffer from a degeneration of their cerebellar Purkinje neurons and retinal photoreceptors that result in a progressive ataxia and loss of vision. As with many neurodegenerative diseases, studies of pathogenesis have been hindered by a lack of disease-relevant models. To this end, we have generated induced pluripotent stem cells (iPSCs) from a cohort of SCA7 patients in South Africa. First, we differentiated the SCA7 affected iPSCs into neurons which showed evidence of a transcriptional phenotype affecting components of STAGA (ATXN7 and KAT2A) and the heat shock protein pathway (DNAJA1 and HSP70). We then performed electrophysiology on the SCA7 iPSC-derived neurons and found that these cells show features of functional aberrations. Lastly, we were able to differentiate the SCA7 iPSCs into retinal photoreceptors that also showed similar transcriptional aberrations to the SCA7 neurons. Our findings give technical insights on how iPSC-derived neurons and photoreceptors can be derived from SCA7 patients and demonstrate that these cells express molecular and electrophysiological differences that may be indicative of impaired neuronal health. We hope that these findings will contribute towards the ongoing efforts to establish the cell-derived models of neurodegenerative diseases that are needed to develop patient-specific treatments.

摘要

脊髓小脑性共济失调 7 型(SCA7)是一种遗传性神经退行性疾病,由 ATXN7 基因中的多聚谷氨酰胺重复扩展引起。患有这种疾病的患者小脑浦肯野神经元和视网膜光感受器退化,导致进行性共济失调和视力丧失。与许多神经退行性疾病一样,发病机制的研究受到缺乏相关疾病模型的阻碍。为此,我们从南非的一组 SCA7 患者中生成了诱导多能干细胞(iPSC)。首先,我们将 SCA7 受影响的 iPSC 分化为神经元,这些神经元表现出影响 STAGA(ATXN7 和 KAT2A)和热休克蛋白途径(DNAJA1 和 HSP70)组件的转录表型的证据。然后,我们对 SCA7 iPSC 衍生的神经元进行了电生理学研究,发现这些细胞表现出功能异常的特征。最后,我们能够将 SCA7 iPSC 分化为视网膜光感受器,这些光感受器也表现出与 SCA7 神经元相似的转录异常。我们的研究结果提供了关于如何从 SCA7 患者中获得 iPSC 衍生神经元和光感受器的技术见解,并表明这些细胞表达的分子和电生理学差异可能表明神经元健康受损。我们希望这些发现将有助于建立神经退行性疾病的细胞衍生模型的持续努力,这是开发针对患者的治疗方法所必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/2c69a623b0b8/pone.0247434.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/d32593c090ec/pone.0247434.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/1baf7d4adf68/pone.0247434.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/c8f5b6fd1125/pone.0247434.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/2c69a623b0b8/pone.0247434.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/d32593c090ec/pone.0247434.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/1baf7d4adf68/pone.0247434.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/c8f5b6fd1125/pone.0247434.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d5c/7904216/2c69a623b0b8/pone.0247434.g004.jpg

相似文献

1
Molecular and electrophysiological features of spinocerebellar ataxia type seven in induced pluripotent stem cells.多能干细胞中脊髓小脑共济失调 7 型的分子和电生理特征。
PLoS One. 2021 Feb 24;16(2):e0247434. doi: 10.1371/journal.pone.0247434. eCollection 2021.
2
Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.脊髓小脑性共济失调 7 型的分子靶点和治疗策略。
Neurotherapeutics. 2019 Oct;16(4):1074-1096. doi: 10.1007/s13311-019-00778-5.
3
Spinocerebellar ataxia Type 7: clinical and genetic study of a new Moroccan family (case report).脊髓小脑共济失调 7 型:一个摩洛哥新家族的临床和遗传学研究(病例报告)。
Pan Afr Med J. 2021 Feb 12;38:162. doi: 10.11604/pamj.2021.38.162.27262. eCollection 2021.
4
Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.靶向突变 Ataxin-7 的反义寡核苷酸可恢复脊髓小脑共济失调 7 型小鼠模型的视觉功能。
Sci Transl Med. 2018 Oct 31;10(465). doi: 10.1126/scitranslmed.aap8677.
5
Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.脊髓小脑共济失调 7 型小脑疾病需要突变型 ataxin-7 在神经元和神经胶质细胞中的协调作用,并且表现出非细胞自主的伯格曼神经胶质变性。
J Neurosci. 2011 Nov 9;31(45):16269-78. doi: 10.1523/JNEUROSCI.4000-11.2011.
6
Hsp70 and Hsp40 chaperones do not modulate retinal phenotype in SCA7 mice.热休克蛋白70(Hsp70)和热休克蛋白40(Hsp40)伴侣蛋白不会调节脊髓小脑共济失调7型(SCA7)小鼠的视网膜表型。
J Biol Chem. 2004 Dec 31;279(53):55969-77. doi: 10.1074/jbc.M409062200. Epub 2004 Oct 19.
7
Progressive degeneration in a new Drosophila model of spinocerebellar ataxia type 7.脊髓小脑共济失调 7 型新型果蝇模型中的进行性退化。
Sci Rep. 2024 Jun 21;14(1):14332. doi: 10.1038/s41598-024-65172-4.
8
SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2.SCA7 小鼠小脑病理学显示关键浦肯野细胞特征基因优先下调,并与 SCA1 和 SCA2 具有共同的疾病特征。
J Neurosci. 2021 Jun 2;41(22):4910-4936. doi: 10.1523/JNEUROSCI.1882-20.2021. Epub 2021 Apr 22.
9
Cross-talking noncoding RNAs contribute to cell-specific neurodegeneration in SCA7.相互作用的非编码RNA促成了SCA7中细胞特异性神经变性。
Nat Struct Mol Biol. 2014 Nov;21(11):955-961. doi: 10.1038/nsmb.2902. Epub 2014 Oct 12.
10
Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.脊髓小脑共济失调7型神经变性的分子发病机制和细胞病理学
Cerebellum. 2008;7(2):138-49. doi: 10.1007/s12311-008-0027-y.

引用本文的文献

1
Advances in the Differentiation of hiPSCs into Cerebellar Neuronal Cells.人诱导多能干细胞向小脑神经元细胞分化的研究进展。
Stem Cell Rev Rep. 2024 Oct;20(7):1782-1794. doi: 10.1007/s12015-024-10763-x. Epub 2024 Jul 18.
2
A microscale soft ionic power source modulates neuronal network activity.微尺度软离子电源调节神经元网络活动。
Nature. 2023 Aug;620(7976):1001-1006. doi: 10.1038/s41586-023-06295-y. Epub 2023 Aug 30.
3
Skeletal Muscle Pathogenesis in Polyglutamine Diseases.多聚谷氨酰胺疾病中的骨骼肌发病机制。

本文引用的文献

1
Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.利用 CRISPR-Cas9 技术生成新的亨廷顿病同基因模型。
Int J Mol Sci. 2020 Mar 8;21(5):1854. doi: 10.3390/ijms21051854.
2
Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7.烟酰胺通路依赖性 Sirt1 激活恢复钙稳态以实现脊髓小脑共济失调 7 型的神经保护作用。
Neuron. 2020 Feb 19;105(4):630-644.e9. doi: 10.1016/j.neuron.2019.11.019. Epub 2019 Dec 16.
3
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
Cells. 2022 Jul 3;11(13):2105. doi: 10.3390/cells11132105.
4
Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling.基于神经退行性疾病患者特异性 iPSC 的模型:聚焦于异常钙信号。
Int J Mol Sci. 2022 Jan 6;23(2):624. doi: 10.3390/ijms23020624.
诱导多能干细胞在多聚谷氨酰胺扩展疾病建模中的应用。
Neurotherapeutics. 2019 Oct;16(4):979-998. doi: 10.1007/s13311-019-00810-8.
4
Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.脊髓小脑性共济失调 7 型的分子靶点和治疗策略。
Neurotherapeutics. 2019 Oct;16(4):1074-1096. doi: 10.1007/s13311-019-00778-5.
5
Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.代谢和细胞器形态缺陷在小鼠和人类患者中定义为脊髓小脑共济失调 7 型为一种线粒体疾病。
Cell Rep. 2019 Jan 29;26(5):1189-1202.e6. doi: 10.1016/j.celrep.2019.01.028.
6
Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.高效的 CRISPR/Cas9 介导的肌强直性营养不良患者来源的 iPS 和肌源性细胞中的三核苷酸重复扩展编辑。
Nucleic Acids Res. 2018 Sep 19;46(16):8275-8298. doi: 10.1093/nar/gky548.
7
A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells.一种从人诱导多能干细胞生成浦肯野细胞的简化方法。
Cerebellum. 2018 Aug;17(4):419-427. doi: 10.1007/s12311-017-0913-2.
8
Self-Organized Cerebellar Tissue from Human Pluripotent Stem Cells and Disease Modeling with Patient-Derived iPSCs.人多能干细胞来源的自发组织小脑组织和患者来源 iPSC 的疾病建模。
Cerebellum. 2018 Feb;17(1):37-41. doi: 10.1007/s12311-017-0905-2.
9
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.通过CRISPR/Cas9介导的基因校正逆转亨廷顿病患者来源的诱导多能干细胞中的表型异常
Stem Cell Reports. 2017 Mar 14;8(3):619-633. doi: 10.1016/j.stemcr.2017.01.022. Epub 2017 Feb 23.
10
Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells.RNA干扰有效靶向SCA7细胞中的突变CAG重复序列。
Genes (Basel). 2016 Dec 17;7(12):132. doi: 10.3390/genes7120132.